Table 1.
Percentage of Patients Who Had 2‐Hour Pain Freedom or 2‐Hour MBS Freedom by Prespecified MBS (mITT Population)
| Photophobia | Phonophobia | Nausea | ||||
|---|---|---|---|---|---|---|
| Placebo, n = 37 | ADAM Zolmitriptan 3.8 mg, n = 42 | Placebo, n = 21 | ADAM Zolmitriptan 3.8 mg, n = 22 | Placebo, n = 19 | ADAM Zolmitriptan = 3.8 mg, n = 18 | |
| 2‐hour pain freedom, n (%) | 5 (14) | 15 (36) | 3 (14) | 9 (41) | 3 (16) | 10 (56) |
| Treatment difference † | 22% | 27% | 40% | |||
| P value ‡ | .02 | .05 | .01 | |||
| 2‐hour MBS freedom, n (%) | 13 (35) | 28 (67) | 9 (43) | 12 (55) | 11 (58) | 16 (89) |
| Treatment difference † | 32% | 12% | 31% | |||
| P value ‡ | <.01 | .45 | .04 | |||
a
ADAM zolmitriptan 3.8 mg minus placebo.
b
ADAM zolmitriptan 3.8 mg vs placebo.